רניביסיו - Ranivisio
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | S01LA Antineovascularisation agents |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ××××××ת ××¢×× - INTRAVITREAL |
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | ⢠For treatment of patients with neovascular (wet) age-related macular degeneration (AMD)⢠For treatment of adult patients with visual impairment due to diabetic macular oedema (DME)⢠For treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)⢠For treatment of visual impairment due to choroidal neovascularization (CNV)⢠For treatment of proliferative diabetic retinopathy (PDR) |
| ×ת××ת ××× ×× | [{{{×ת××ת ××× ××}}} Posology and method of administration] |
| ×ת××××ת × ×× | [{{{×ת××××ת × ××}}} Contraindications] |
| ת×פע×ת ××××× | [{{{ת×פע×ת ×××××}}} Undesirable effects] |
| ת××××ת ××× ×ª×¨×פת××ת | [{{{ת××××ת ××× ×ª×¨×פת××ת}}} Interaction with other medicinal products and other forms of interaction] |
| ש×××ש ×××ר××× ××× ×§× | [{{{ש×××ש ××ר××× ××× ×§×}}} Pregnancy and Lactation] |
| פר×ק×××× ×××§× | [{{{פר×ק×××× ××ק×}}} Pharmacodynamic Properties] |
| פר×ק×ק×× ×××§× | [{{{פר×ק×ק×× ××ק×}}} Pharmacokinetic Properties] |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×¨× ×××ס×× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | BIOEQ AG, SWITZERLAND |
| ×©× ××¢× ×ר×ש×× | DEXCEL LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 11/2023. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 06/08/2024 |
השינוי האחרון נעשה בֹ־6 באוגוסט 2024 ב־07:25